Current Status of Probiotics as Supplements in the Prevention and Treatment of Infectious Diseases
Xinquan Li, Qiang Wang, Xiafen Hu, Wanxin Liu
Frontiers in Cellular and Infection Microbiology
Abstract
Probiotics play an important role against infectious pathogens <i>via</i> their effects on the epithelium, the production of antimicrobial compounds, and competitive exclusion. Administration of probiotic supplements may reduce the risk of infectious diseases and the use of antibiotics, hence contributing to a reduction or a delay of the development of multi-resistant bacteria. Infection is a constant concern for people who experience recurrent infections, and antibiotic treatment usually fails due to antibiotic resistance. Therefore, an infection can lead to severe illness and hospitalization if left untreated. A growing number of studies have demonstrated promising results for a variety of probiotic strains used to prevent or treat acute and recurrent infectious diseases, but additional standardized clinical research is needed.
Extracted Claims
5 claims extracted from this paper into the knowledge graph
MWP and CD have aroma releases most similar to full-fat emulsion
“The aroma releases of the emulsions comprising MWP and CD were most similar to that of the full-fat emulsion.”
all four fat replacers improve lubricity of reduced-fat samples
“All four fat replacers improved the lubricity of the reduced-fat samples.”
butane-2,3-dione and 3-methylbutanoic acid are less affected by changes in formulation
“Butane-2,3-dione and 3-methylbutanoic acid were less affected by the changes in the formulation than butanoic acid, heptan-2-one, ethyl butanoate, and nonan-2-one.”